John Harlan

John Harlan

Company: AbbVie

Job title: Senior Principal Research Scientist

Seminars:

Live Discussion & Question Time 2:30 pm

Read more

day: Track A - Day 2 PM

Site-Specific Conjugation: Impacts of C6 Variant Position on Antibody & ADC Properties 1:30 pm

In order to minimise ADC heterogeneity in both position and drug load, site-specific conjugation is rapidly becoming a preferred method for drug attachment Cys-deletion is one strategy where-by site-specific conjugation can be achieved without adding cysteines to the antibodyRead more

day: Track A - Day 2 PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.